Natco Pharma Q2 Net Profit Falls 60.8% Amid Revenue Decline
Natco Pharma reported a 60.8% decline in consolidated net profit to Rs 202.6 crore for Q2 FY27, primarily due to a 29% drop in revenue to Rs 967.3 crore. Total expenses decreased by 8.6% to Rs 776.2 crore but did not offset the revenue fall. For the first half of FY27, net profit fell 59% to Rs 409.1 crore. During the quarter, Natco acquired an additional 13.25% stake in Adcock Ingram Holding Ltd and approved an interim dividend of Rs 1.25 per share.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (40/100). Lens Score 37/100.
Outlets measured: freepressjournal, businessstandard, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (38–45/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 13 Nov, 10:15 am. Other outlets followed.